ELEM Biotech
ELEM Biotech is a biomedical simulation spin-off from the Barcelona Supercomputing Center that creates populations of virtual humans to predict outcomes of pharmacological and medical device therapeutics. Their supercomputer-based in-silico trials serve pharmaceutical, Medtech companies, and CROs from discovery through clinical phases. Their technology includes a cloud-deployed platform simulating cardiovascular and respiratory systems with multi-physics biomedical simulations, enabling virtual clinical trials, product optimization, and patient personalization. ELEM's platform leverages the Alya Red simulation code developed since 2005, using supercomputing power to model virtual patients and populations, aiming to revolutionize medical innovation, testing, and regulatory approval processes.
ELEM Biotech
ELEM Biotech is a biomedical simulation spin-off from the Barcelona Supercomputing Center that creates populations of virtual humans to predict outcomes of pharmacological and medical device therapeutics. Their supercomputer-based in-silico trials serve pharmaceutical, Medtech companies, and CROs from discovery through clinical phases. Their technology includes a cloud-deployed platform simulating cardiovascular and respiratory systems with multi-physics biomedical simulations, enabling virtual clinical trials, product optimization, and patient personalization. ELEM's platform leverages the Alya Red simulation code developed since 2005, using supercomputing power to model virtual patients and populations, aiming to revolutionize medical innovation, testing, and regulatory approval processes.
